LABT ▲ +12.6% - Lakewood-Amedex Biotherapeutics, Inc. $LABT - Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3 Lakewood-Amedex Biotherapeutics shares rose 12.6% following a CEO letter to shareholders that highlighted transformational progress and the outlook for the company's Nu-3 program. The positive messaging about advancement in the pipeline candidate appears to have boosted investor confidence in the biotech firm's direction. 21-SEP-2026 08:02 AM ET